LeMaitre Vascular Operating Margin 2010-2025 | LMAT

Current and historical operating margin for LeMaitre Vascular (LMAT) over the last 10 years. The current operating profit margin for LeMaitre Vascular as of June 30, 2025 is 20.08%.
LeMaitre Vascular Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-06-30 $0.24B $0.06B 23.40%
2025-03-31 $0.23B $0.05B 23.35%
2024-12-31 $0.22B $0.05B 23.64%
2024-09-30 $0.21B $0.05B 23.00%
2024-06-30 $0.21B $0.05B 21.95%
2024-03-31 $0.20B $0.04B 20.10%
2023-12-31 $0.19B $0.04B 18.65%
2023-09-30 $0.19B $0.03B 17.84%
2023-06-30 $0.18B $0.03B 16.95%
2023-03-31 $0.17B $0.03B 15.98%
2022-12-31 $0.16B $0.03B 16.67%
2022-09-30 $0.16B $0.03B 17.39%
2022-06-30 $0.16B $0.03B 19.38%
2022-03-31 $0.16B $0.04B 22.64%
2021-12-31 $0.16B $0.04B 23.23%
2021-09-30 $0.15B $0.04B 24.84%
2021-06-30 $0.15B $0.04B 25.83%
2021-03-31 $0.14B $0.03B 24.44%
2020-12-31 $0.13B $0.03B 22.31%
2020-09-30 $0.12B $0.02B 19.67%
2020-06-30 $0.12B $0.02B 17.39%
2020-03-31 $0.12B $0.02B 17.65%
2019-12-31 $0.12B $0.02B 18.10%
2019-09-30 $0.11B $0.02B 20.18%
2019-06-30 $0.11B $0.02B 20.18%
2019-03-31 $0.11B $0.03B 26.17%
2018-12-31 $0.11B $0.03B 27.62%
2018-09-30 $0.10B $0.03B 27.18%
2018-06-30 $0.10B $0.03B 26.92%
2018-03-31 $0.10B $0.02B 21.36%
2017-12-31 $0.10B $0.02B 20.79%
2017-09-30 $0.10B $0.02B 19.39%
2017-06-30 $0.10B $0.02B 19.79%
2017-03-31 $0.09B $0.02B 18.48%
2016-12-31 $0.09B $0.02B 18.18%
2016-09-30 $0.09B $0.02B 17.65%
2016-06-30 $0.08B $0.01B 16.05%
2016-03-31 $0.08B $0.01B 15.19%
2015-12-31 $0.08B $0.01B 14.10%
2015-09-30 $0.08B $0.01B 14.29%
2015-06-30 $0.08B $0.01B 13.16%
2015-03-31 $0.07B $0.01B 12.16%
2014-12-31 $0.07B $0.01B 9.72%
2014-09-30 $0.07B $0.01B 7.04%
2014-06-30 $0.07B $0.00B 5.88%
2014-03-31 $0.07B $0.00B 4.55%
2013-12-31 $0.06B $0.00B 6.25%
2013-09-30 $0.06B $0.00B 6.56%
2013-06-30 $0.06B $0.00B 6.67%
2013-03-31 $0.06B $0.00B 6.90%
2012-12-31 $0.06B $0.00B 7.02%
2012-09-30 $0.06B $0.00B 7.27%
2012-06-30 $0.06B $0.01B 8.93%
2012-03-31 $0.06B $0.01B 8.77%
2011-12-31 $0.06B $0.00B 6.90%
2011-09-30 $0.06B $0.00B 3.39%
2011-06-30 $0.06B $0.00B 3.45%
2011-03-31 $0.06B $0.00B 5.26%
2010-12-31 $0.06B $0.00B 7.14%
2010-09-30 $0.06B $0.01B 10.71%
2010-06-30 $0.06B $0.01B 9.09%
2010-03-31 $0.05B $0.00B 7.41%
2009-12-31 $0.05B $0.00B 1.96%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.089B $0.220B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.709B 27.40
Boston Scientific (BSX) United States $152.828B 36.44
Stryker (SYK) United States $144.352B 29.38
EssilorLuxottica (ESLOY) France $136.813B 0.00
Medtronic (MDT) Ireland $119.054B 16.89
Lonza Group Ag (LZAGY) Switzerland $47.435B 0.00
Haleon (HLN) United Kingdom $42.853B 24.46
ResMed (RMD) United States $41.628B 29.73
GE HealthCare Technologies (GEHC) United States $32.872B 15.45
Agilent Technologies (A) United States $32.560B 21.23
Terumo (TRUMY) Japan $27.538B 32.63
Koninklijke Philips (PHG) Netherlands $25.845B 17.10
Insulet (PODD) United States $21.612B 72.43
Zimmer Biomet Holdings (ZBH) United States $19.663B 12.52
Smith & Nephew SNATS (SNN) United Kingdom $15.829B 0.00
Baxter (BAX) United States $12.168B 9.40
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.599B 0.00
Bio-Rad Laboratories (BIO) United States $7.150B 26.26
Lantheus Holdings (LNTH) United States $3.889B 10.52
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.364B 23.53
Prestige Consumer Healthcare (PBH) United States $3.227B 14.32
Perrigo (PRGO) Ireland $3.102B 7.75
ICU Medical (ICUI) United States $2.786B 18.97
Haemonetics (HAE) United States $2.601B 11.61
AtriCure (ATRC) United States $1.755B 0.00
QuidelOrtho (QDEL) United States $1.624B 10.22
Green Thumb Industries (GTBIF) United States $1.509B 64.82
Curaleaf Holdings (CURLF) Canada $1.368B 0.00
AdaptHealth (AHCO) United States $1.240B 17.67
Phibro Animal Health (PAHC) United States $1.139B 14.56
Acuren (TIC) United States $1.138B 0.00
Neogen (NEOG) United States $1.103B 17.52
BioLife Solutions (BLFS) United States $1.086B 2268.00
InMode (INMD) Israel $0.892B 8.25
Valneva SE (VALN) France $0.775B 0.00
Kestra Medical Technologies (KMTS) United States $0.746B 0.00
Tilray Brands (TLRY) Canada $0.714B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.560B 0.00
Owens & Minor (OMI) United States $0.548B 4.54
ZimVie (ZIMV) United States $0.530B 20.45
Surmodics (SRDX) United States $0.506B 0.00
CeriBell (CBLL) United States $0.473B 0.00
SNDL (SNDL) Canada $0.441B 0.00
Capricor Therapeutics (CAPR) United States $0.414B 0.00
VAREX IMAGING (VREX) United States $0.393B 13.54
Evolus (EOLS) United States $0.382B 0.00
Cresco Labs (CRLBF) United States $0.367B 0.00
Verano Holdings (VRNOF) United States $0.347B 0.00
Sanuwave Health (SNWV) United States $0.341B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Viemed Healthcare (VMD) United States $0.275B 20.88
Canopy Growth (CGC) Canada $0.256B 0.00
Aurora Cannabis (ACB) Canada $0.253B 0.00
Omeros (OMER) United States $0.251B 0.00
Cerus (CERS) United States $0.232B 0.00
Brainsway (BWAY) Israel $0.222B 58.80
Quanterix (QTRX) United States $0.221B 0.00
Sanara MedTech (SMTI) United States $0.220B 0.00
Vireo Growth (VREOF) United States $0.214B 0.00
OraSure Technologies (OSUR) United States $0.203B 0.00
Exagen (XGN) United States $0.202B 0.00
Organigram Global (OGI) Canada $0.194B 0.00
Utah Medical Products (UTMD) United States $0.183B 15.06
High Tide (HITI) Canada $0.176B 0.00
TerrAscend (TSNDF) Canada $0.170B 0.00
Biote (BTMD) United States $0.158B 4.72
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
Safety Shot (SHOT) United States $0.138B 0.00
FitLife Brands (FTLF) United States $0.136B 0.00
Jushi Holdings (JUSHF) United States $0.133B 0.00
Jin Medical (ZJYL) China $0.103B 0.00
MacroGenics (MGNX) United States $0.097B 0.00
Fonar (FONR) United States $0.096B 12.33
Quipt Home Medical (QIPT) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Agape ATP (ATPC) $0.068B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Veru (VERU) United States $0.055B 0.00
Zynex (ZYXI) United States $0.044B 0.00
Nephros (NEPH) United States $0.041B 32.50
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.036B 14.11
Rockwell Medical (RMTI) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Trinity Biotech (TRIB) Ireland $0.017B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Senestech (SNES) United States $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00